Ascendis Pharma (ASND) PT Lowered to $304 at BofA Securities

September 1, 2026 6:59 AM

BofA Securities analyst Tazeen Ahmad lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $304.00 (from $306.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found